These inconsistent effects of type I IFNs on different BC types may depend on the tumor microenvironment, such as the differential composition of stroma cells including cancer-associated adipocytes, and IFN-responding intracellular contexts, such as the ISGs. The gene discussed is IFNA1; the disease is breast cancer.